Schedule 13G ownership disclosure

AKARI THERAPEUTICS PLC

Ordinary Shares, $0.0001 par value · CUSIP: 00972G207

Event date: 2024-11-14

Filing-level shares
8,294,508,000
Percent of class
15.5%
  • Hoyoung Huh, M.D., Ph.D.

    Shares: 8,294,508,000 · Class: 15.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-021396
Form type
SCHEDULE 13G
Filer
Akari Therapeutics Plc
CIK
CIK 1541157
Filed
Feb 14, 2025
Reporting period
Nov 14, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub